Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Change in Accured Expenses (2018 - 2026)

Alector's (ALEC) quarterly Change in Accured Expenses came in at -$2.8 million in Q2 2026, up 26.87% year-over-year from -$2.2 million in Q2 2025, and up 74.89% quarter-over-quarter from -$11.0 million in Q1 2026.

Analysis

Alector (ALEC) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Change in Accured Expenses for 9 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 26.87% year-over-year to -$2.8 million in Q2 2026; TTM through Jun 2026 was -$10.2 million, a 60.8% decrease from a year earlier, with the FY2025 full-year figure at -$12.9 million, down 3895.29% from the prior year.
  • Change in Accured Expenses was -$2.8 million for Q2 2026 at Alector, up from -$11.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $8.0 million in Q3 2023 and troughed at -$12.7 million in Q1 2025.
  • A 5-year average of -$1.5 million and a median of -$1.6 million in 2022 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses jumped 823.83% in 2023 and slumped 900.21% in 2025, its largest moves.
  • Over 5 years, Change in Accured Expenses stood at $4.6 million in 2022, then tumbled by 145.79% to -$2.1 million in 2023, then jumped by 420.84% to $6.8 million in 2024, then tumbled by 84.0% to $1.1 million in 2025, then slumped by 354.18% to -$2.8 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$2.8 million (Q2 2026), -$11.0 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 852.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 338.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 222.50 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 492.70 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 11.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 61.62 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -49.70 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 68.82 Mn
10 Alector 274.68 Mn 101.88 Mn - -2.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.77 Mn
Mar 31, 2026 -11.02 Mn
Dec 31, 2025 1.09 Mn
Sep 30, 2025 2.51 Mn
Jun 30, 2025 -3.79 Mn
Mar 31, 2025 -12.72 Mn
Dec 31, 2024 6.81 Mn
Sep 30, 2024 3.37 Mn
Jun 30, 2024 473,000.00
Mar 31, 2024 -10.30 Mn
Dec 31, 2023 -2.12 Mn
Sep 30, 2023 8.05 Mn
Jun 30, 2023 3.64 Mn
Mar 31, 2023 -7.02 Mn
Dec 31, 2022 4.63 Mn
Sep 30, 2022 -1.11 Mn
Jun 30, 2022 -2.79 Mn
Mar 31, 2022 -3.38 Mn
Dec 31, 2021 7.88 Mn
Sep 30, 2021 -1.26 Mn